Farah Champsi insider trades: Allakos (ALLK) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Farah reports to the SEC
and 19 more companies
Open-market buys and sales
44 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Jul 23, 2018 | ALLK | ↑ Buy | 250,000 | $18.00 | $4.5M | Indirect | Jul 23, 2018 (0d) |
| Jun 16, 2017 | KITE | ↓ Sell | 5,450 | $88.11 | $480K | Indirect | Jun 16, 2017 (0d) |
| Jun 14, 2017 | KITE | ↓ Sell | 15,000 | $90.40 | $1.4M | Direct | Jun 16, 2017 (2d) |
| Apr 28, 2017 | KITE | ↓ Sell | 19,168 | $82.75 | $1.6M | Indirect | May 1, 2017 (3d) |
| Apr 26, 2017 | KITE | ↓ Sell | 123,913 | $82.67 | $10.2M | Indirect | Apr 26, 2017 (0d) |
| Apr 17, 2017 | KITE | ↓ Sell | 115,376 | $82.42 | $9.5M | Indirect | Apr 17, 2017 (0d) |
| Dec 30, 2015 | NEOT | ↓ Sell | 797,987 | $1.51 | $1.2M | Direct | Dec 30, 2015 (0d) |
| Dec 15, 2015 | NEOT | ↓ Sell | 529,261 | $1.44 | $762K | Direct | Dec 17, 2015 (2d) |
| Jun 30, 2015 | KITE | ↓ Sell | 664,102 | $62.35 | $41.4M | Indirect | Jul 2, 2015 (2d) |
| Jun 8, 2015 | ZSPH | ↓ Sell | 175,427 | $57.86 | $10.1M | Direct | Jun 9, 2015 (1d) |
| Jun 4, 2015 | ZSPH | ↓ Sell | 111,597 | $57.30 | $6.4M | Direct | Jun 5, 2015 (1d) |
| Jun 2, 2015 | ZSPH | ↓ Sell | 296,423 | $58.00 | $17.2M | Direct | Jun 2, 2015 (0d) |
| Dec 10, 2014 | TRVN | ↑ Buy | 500,000 | $4.00 | $2.0M | Indirect | Dec 10, 2014 (0d) |
| Nov 25, 2014 | NEOT | ↓ Sell | 149,286 | $14.00 | $2.1M | Alta Partners VIII, LP | Nov 25, 2014 (0d) |
| Nov 25, 2014 | NEOT | ↑ Buy | 70,000 | $14.00 | $980K | Alta Partners VIII, LP | Nov 25, 2014 (0d) |
| Oct 21, 2014 | ESPR | ↑ Buy | 500,000 | $20.00 | $10.0M | Indirect | Oct 21, 2014 (0d) |
| Jul 29, 2014 | IMDZ | ↑ Buy | 299,559 | $12.00 | $3.6M | Direct | Jul 31, 2014 (2d) |
| Jun 23, 2014 | ZSPH | ↑ Buy | 200,000 | $18.00 | $3.6M | Direct | Jun 25, 2014 (2d) |
| May 7, 2014 | SCYX | ↑ Buy | 868,066 | $10.00 | $8.7M | Direct | May 8, 2014 (1d) |
| May 7, 2014 | SCYX | ↑ Buy | 31,934 | $10.00 | $319K | By Alta Embarcadero BioPharma Partners I | May 8, 2014 (1d) |
| Apr 1, 2014 | AGTC | ↑ Buy | 155,645 | $12.00 | $1.9M | Indirect | Apr 1, 2014 (0d) |
| Feb 5, 2014 | TRVN | ↑ Buy | 472,410 | $7.00 | $3.3M | Indirect | Feb 7, 2014 (2d) |
| Feb 5, 2014 | CARA | ↑ Buy | 112,817 | $11.00 | $1.2M | Indirect | Feb 5, 2014 (0d) |
| Oct 23, 2013 | CMRX | ↓ Sell | 447,499 | $15.51 | $6.9M | Indirect | Oct 23, 2013 (0d) |
| Jul 1, 2013 | ESPR | ↑ Buy | 235,714 | $14.00 | $3.3M | Indirect | Jul 1, 2013 (0d) |
| Oct 16, 2012 | AEGR | ↓ Sell | 183,855 | $18.33 | $3.4M | Direct | Oct 17, 2012 (1d) |
| Oct 16, 2012 | AEGR | ↓ Sell | 16,878 | $18.33 | $309K | Indirect | Oct 17, 2012 (1d) |
| Aug 9, 2011 | AEGR | ↑ Buy | 9,700 | $12.44 | $121K | Direct | Aug 9, 2011 (0d) |
| Oct 27, 2010 | AEGR | ↑ Buy | 315,789 | $9.50 | $3.0M | Direct | Oct 27, 2010 (0d) |
| Jun 30, 2010 | SNSS | ↑ Buy | 10,910,596 | $0.28 | $3.0M | Direct | Jul 2, 2010 (2d) |
| Jun 30, 2010 | SNSS | ↑ Buy | 1,001,628 | $0.28 | $275K | Indirect | Jul 2, 2010 (2d) |
| Jan 6, 2010 | ANSV | ↓ Sell | 372,999 | $0.09 | $34K | Direct | Jan 8, 2010 (2d) |
| Jan 6, 2010 | ANSV | ↓ Sell | 30,612 | $0.09 | $3K | By ACP III, LP | Jan 8, 2010 (2d) |
| Jan 6, 2010 | ANSV | ↓ Sell | 1,039 | $0.09 | $95 | By AEP III, LLC | Jan 8, 2010 (2d) |
| Dec 14, 2009 | SNSS | ↓ Sell | 2,044,750 | $2.01 | $4.1M | Direct | Dec 16, 2009 (2d) |
| Dec 14, 2009 | SNSS | ↓ Sell | 187,714 | $2.01 | $377K | By Fund | Dec 16, 2009 (2d) |
| Oct 16, 2009 | CORT | ↑ Buy | 337,245 | $1.38 | $465K | Direct | Oct 20, 2009 (4d) |
| Oct 16, 2009 | CORT | ↑ Buy | 12,406 | $1.38 | $17K | By Side Fund | Oct 20, 2009 (4d) |
| Oct 5, 2009 | THLD | ↑ Buy | 239,768 | $1.91 | $458K | Direct | Oct 6, 2009 (1d) |
| Oct 5, 2009 | THLD | ↑ Buy | 22,012 | $1.91 | $42K | Indirect | Oct 6, 2009 (1d) |
| Sep 8, 2009 | TPTX | ↓ Sell | 717,837 | $0.22 | $161K | Indirect | Sep 8, 2009 (0d) |
| Mar 25, 2008 | CORT | ↑ Buy | 1,059,135 | $2.77 | $2.9M | By Fund | Mar 26, 2008 (1d) |
| Oct 14, 2005 | CTRX | ↓ Sell | 166,937 | $13.00 | $2.2M | Indirect | Oct 18, 2005 (4d) |
| Oct 12, 2005 | CTRX | ↓ Sell | 247,314 | $13.00 | $3.2M | Indirect | Oct 14, 2005 (2d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Farah Champsi's insider trades
Farah Champsi is a 10% owner of Allakos (ALLK). Since Oct 12, 2005, Farah has reported 21 open-market purchases worth $53.7M and 23 sales worth $123.1M on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include conversions (17 filings), other transactions (13 filings), grants and awards (6 filings), shares returned to the company (3 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every ALLK insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.